Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism

Fig. 2

14 compounds were selected and analysed using MTT- or SRB Assay in HT-29, MCF-7 and MDA-MB-231 cells in order to obtain dose response curves and EC50. A minimalistic drug interaction screening (MDIS) was applied to detect synergies in the 91 possible combinations. The combinations with the most synergistic potential were then further verified

Back to article page